ERAP2 and Stevens-Johnson syndrome: So far, the only observation reported has been the interaction of genetic variation in ERAP2, in high LD with rs2910788 reported here, and HLA-C*04:01 influencing the risk of Stevens-Johnson syndrome/toxic epidermal necrosis secondary to nevirapine49.